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 The purpose of this study is to know the concentration of boron and 
irradiation times which optimizes the treatment of breast cancer using 
the BNCT method. This research was conducted by using MCNPX 
simulation which outputs are flux neutron, neutron scattering dose and 
gamma dose. The neutron source used is the BSA D-D Neutron 
generator model. The independent variable of this research is the boron 
concentration injected into the cancer. The dependent variable is the 
total dose rate and irradiation time which determines the effectiveness of  
BNCT therapy. The controlled variables are the output of the neutron 
flux, dose and gamma neutron scattering dose. The results showed that 
in the range of 70-150 µg/g, the dose rate received by cancer increases 
with increasing the concentration of boron-10. If the dose rate is 
increased, the irradiation time interval will be faster. The Boron dose of 
70 μg/g and the dose rate of irradiation 0.00293603 Gy/sec needs an 
irradiation time of 409.43 minutes; the boron dose of 90 µg/g and the 
dose rate of irradiation 0.00241049 Gy/sec needs an irradiation time of 
345.71 minutes; the boron dose of 110 µg/g and the dose rate of 
irradiation 0.00271236 Gy/sec needs an irradiation time of 307.24 
minutes; the boron dose of 130 µg/g and the dose rate of irradiation 
0.00303389 Gy/sec needs an irradiation time of 274.67 minutes; and the 
boron dose 150 µg/g and the dose rate of irradiation 0.00334565 Gy/sec 
needs an irradiation time of 249.08 minutes. The Optimum 
concentration of boron is 150 µg/g with irradiation time of 249.08 
minutes. 
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1. INTRODUCTION 
Cancer is the uncontrolled proliferation of 
cells or tissues. As mention by the Indonesian 
Health Ministry (2013), cancer is the 2nd 
leading cause of death (13% from all 22% 
death) caused by non infected diseases in the 
world [Oemita et al, 2011]. Details of cancer 
caused death in Indonesia is 103,100 males and 
92,200 females [WHO, 2014]. Frequent cancer 
cases that occur in males include lung cancer, 
prostate cancer and cholesterol cancer that 
translates to approximately 21.8% of all cancer 
cases, while in females, breast cancer equates 
to approximately 21.4% from all cancer cases. 
                                                    
 E-mail: sardjono.batan@gmail.com 
BNCT is a new radiotherapy method that 
is  being developed after many cancer therapies 
have displayed negative side effects towards 
patients. These methods include radiotherapy, 
surgery, chemotherapy and/or the combination 
of the three. Among the three methods as 
mentioned, BNCT is one radiotherapy method 
that has the potential to be developed. 
Another important thing beside neutron 
sources and boron carrier for BNCT is setting 
the radiation dose received by the body, and so 
considering the quality of neutron radiation 
which is used for treatment [Huang, 2009]. 
These dosing devices must ensure the safety 
and optimal treatment. Safety means that the 
side effects of the treatment are limited to as 
little as possible. Optimal means the organ 
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affected by cancer receives as much treatment 
dose as possible and has an irradiation time that 
is as short as possible. 
Research of BNCT has been done by Dian 
Noviati (2013) for breast cancer therapy. This 
research compares irradiation time in breast 
cancer with a boron concentration range of 20-
70 µg/g using MCNP5. The results show that 
for BNCT the minimum irradiation time occurs 
when the boron concentration is 70 µg/g 
[Noviati, 2013]. Therefore, research about the 
dose received for breast cancer needs to be 
done so that safety and the optimum dose for 
BNCT treatment can be achieved. 
2. MATERIALS AND METHODS 
Design of the BSA and breast cancer were 
done using MCNPX. Dose distribution and 
irradiation time has been performed and 
calculated for each variation of boron 
concentration, i.e. 70 µg/g, 90 µg/g, 110 µg/g, 
130 µg/g, and 150 µg/g. The neutron energy  
used are epithermal neutrons with a flux of 
8.05 x 108 neutron/cm2 s [Gulo, 2012]. 
The cancer cells were made as a sphere 
with a diameter of 3 cm, while the skin is a 
semi-circular shape with a thickness of 0.25 
cm, ribs are tubes with diameters of 1.5 cm and 
15 cm in length, and the geometry of the breast 
is a half circle with a diameter of 14 cm. In 
modeling, the cancer cells are considered to be 
situated in the middle of the breast. Cancer cell 
density is assumed to be 10% greater than the 
density of the normal breast tissue so that the 
density-value is 1.12 g/cm3. 
This research was conducted in several 
steps. The first step was to prepare the data and 
study library material. Second, to create the 
geometry of the cancer and healthy tissue that 
is placed in front of the BSA, then calculate the 
fraction of atoms to be used in data cards in 
MCNPX variation in the dose range of 70-150 
mg/g. This is followed by running the program 
on each of the boron concentrations. The 
output of MCNPX will be analyzed to calculate 
the radiation dose and the time required for 
irradiation. 
3. RESULTS AND DISCUSSION 
Epithermal neutron flux is used in BNCT 
therapy so that the neutron is moderated when 
it passes through the body into thermal 
neutrons so that the energy received by the 
cancer under the surface is low, which reduces 
the dose received by the skin. Figure 2 (a and 
b) shows a side view of the NG BSA design 
and breast tissue. Every human being has 
varying characteristics and different breast 
sizes but the simulated breast size is based on 
the average breast size. 
 
(a) 
 
 
 
(b) 
Fig 1. Design of BSA and breast tissue use MCNPX (a) 
geometry of BSA and breast tissue design (b) geometry 
of breast tissue  
 
 
Depth (cm) 
Fig 2. Neutorn flux due to the depth in tissue 
Based on Figure 2, it is known that the 
epithermal neutron flux has a greater value than 
the thermal neutron flux, while the value of 
thermal neutron flux is below the epithermal 
Information:  
1. Skin  
2. Healthy tissue  
3. Planning Target Volume 
(PTV)  
4. Clinical Target Volume 
(CTV)  
5. Gross Tumor Volume 
(GTV)  
6. Rib 
Indonesian Journal of Physics and Nuclear Application, Vol.4, No.1, February 2019 
  
10
neutrons and gradually declines faster until it  
approaches 0.00. Epithermal neutron flux 
increased with the depth of tissue, before 
declining. This happens because of the 
decreased energy of epithermal neutron 
(moderated) into thermal neutrons that interact 
with components of the tissue. The flux values 
obtained by the tissue will also affect the value 
of the total absorbed dose received by the 
tissues of the body. 
Thermal and epithermal neutron flux at 
different tissue depths were obtained after 
concentrations of 10B were varied in the 
cancer. The fourth dose also has each weight 
factor. Differences in factors are influenced by 
the sensitivity of the target tissue and Linear 
Energy Transfer (LET) of each dose. The 
weighting factors affect the value of the 
absorbed dose received by the tissues of the 
body. Table 1 shows the distribution of the 
dose rate in cancer tissues with various 
concentrations of boron. 
Table 1. Dose rate in cancer cell 
 
Total dose rate at the cancerous tissue 
tends to increase for each increased boron 
concentration. This happens because healthy 
tissue only receives 0.3% of the boron the 
cancerous tissue receives. This value is 
obtained from the infusion method i.c ie with a 
ratio of 10: 1. Cancer received high doses, as 
high as the boron concentration that was 
injected into the body. This will speed up the 
healing process. 
Table 2 shows the irradiation time required 
for each of the different boron concentrations 
in cancer tissue. 
 
Table 2. Irradiation time due to boron concentration. 
 
 In Table 2, the boron concentration of 70 
ug/g required an irradiation time of 409.43 
minutes while the highest concentration of 150 
ug/g needed a faster time of 249.0824 minutes. 
Fast irradiation time is reached when the boron 
concentration is high, so that the dose rate in 
the cancer cell is high. This is because the high 
boron concentration can increase the 
probability of interaction between neutron and 
boron, thus affecting the production of the 
alpha particle which is used to kill the cancer. 
Skin is one of the body tissues that will 
experience acute effects when exposed to 
radiation. The acute effects of this will occur 
after irradiation is done. Effects will arise 
normally in the form of erythema, moist 
desquamation and ulceration (pus). Erythema 
occurs when the skin receives a dose larger 
than 6 Gy while moist desquamation and 
ulceration occurs after receiving a dose of 20-
25 Gy. Therefore, the number of doses in the 
skin must be taken into consideration in the 
implementation of BNCT treatment so that the 
skin receives a dose of less than 6 Gy to avoid 
the effects of erythema (Novianti, 2013). Table 
19 shows the results of the dose absorbed by 
each organ according to the result of 
calculations. 
 
Table 3. Type Dose absorbed y each organs. 
 
 The table shows that the dose received by 
skin is less than 6 Gy when using a boron 
concentration of 150 ug/g. The absorbed dose 
in the skin declines steadily with increasing 
concentrations of boron. The dose absorbed by 
other organs is reduced when granting enlarged 
concentrations as well, which is expected and 
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is below the safe limit for each organ. In this 
study, the dose received by the skin, breast 
healthy tissue and ribs is at a concentration of 
150 ug/g, which is 1.8 Gy, 3.1 Gy and 1.7 Gy, 
respectively. This shows that there are no side 
effects in the skin because the dose is within 
the safe level, ie below 2 Gy, since epilation 
and dry desquamation occurs in the range of 3-
12 Gy. 
 
4. CONCLUSION AND REMARKS 
 It can be concluded that the higher the 
concentration of boron in breast cancer therapy 
using BSA NG results in a lower irradiation 
time when the dose is within 70-150 mg/g. The 
optimal dose of boron based on the results of 
the research is at a concentration of 150 ug / g. 
The time required for the irradiation of breast 
cancer increases rapidly at concentrations 
greater than 150 ug/g, with an irradiation time 
of 249.08 minutes or 4 hours 15 seconds. 
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